Óscar Solís

Pharmacological and behavioral divergence of ketamine enantiomers: implications for abuse liability

Jordi Bonaventura, Sherry Lam, Meghan L. Carlton et al. · Molecular Psychiatry · 2021 · 246 citations · Full text

Ketamine Enantiomers, Substance Abuse, Psychoactive Drug +11

L-DOPA Treatment Selectively Restores Spine Density in Dopamine Receptor D2–Expressing Projection Neurons in Dyskinetic Mice

Luz M. Suárez, Óscar Solís, José María Caramés et al. · Biological Psychiatry · 2013 · 176 citations · Full text

Molecular Neuroscience, Dyskinetic Mice, Neuropharmacology +8

L-DOPA Oppositely Regulates Synaptic Strength and Spine Morphology in D1 and D2 Striatal Projection Neurons in Dyskinesia

Luz M. Suárez, Óscar Solís, Carolina Aguado et al. · Cerebral Cortex · 2016 · 117 citations · Full text

Spine Morphology, Synaptic Plasticity, Dopamine Depletion +13

Dopamine D3 Receptor Modulates l-DOPA-Induced Dyskinesia by Targeting D1 Receptor-Mediated Striatal Signaling

Óscar Solís, José Rubén García-Montes, Aldo Efrain González-Granillo et al. · Cerebral Cortex · 2015 · 99 citations · Full text

Molecular Markers, Dopamine D3 Receptor, Functional Selectivity +9

Alterations in dendritic morphology of the prefrontal cortical and striatum neurons in the unilateral 6‐OHDA‐rat model of Parkinson's disease

Óscar Solís, Ilhuicamina Daniel Limón, Jorge Flores‐Hernández et al. · Synapse · 2007 · 91 citations